SWP
MRNA icon

Stratos Wealth Partners’s Moderna MRNA Stock Holding History

Stratos Wealth Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,940
Closed -$263K – 1509
2024
Q3 		$263K Buy
3,940
+291
+8% +$26.7K ﹤0.01% 1212
2024
Q2 		$433K Sell
3,649
-2,043
-36% -$259K 0.01% 957
2024
Q1 		$607K Buy
5,692
+547
+11% +$55.1K 0.01% 825
2023
Q4 		$512K Sell
5,145
-1,126
-18% -$94.7K 0.01% 872
2023
Q3 		$648K Sell
6,271
-1,689
-21% -$188K 0.01% 724
2023
Q2 		$967K Buy
7,960
+1,811
+29% +$242K 0.02% 542
2023
Q1 		$944K Sell
6,149
-942
-13% -$155K 0.03% 501
2022
Q4 		$1.27M Buy
7,091
+61
+0.9% +$9.97K 0.03% 445
2022
Q3 		$831K Sell
7,030
-2,226
-24% -$338K 0.02% 538
2022
Q2 		$1.32M Sell
9,256
-516
-5% -$73.8K 0.03% 424
2022
Q1 		$1.68M Buy
9,772
+1,056
+12% +$178K 0.04% 408
2021
Q4 		$2.21M Sell
8,716
-6,557
-43% -$1.92M 0.05% 334
2021
Q3 		$5.88M Sell
15,273
-2,238
-13% -$825K 0.15% 151
2021
Q2 		$4.12M Buy
17,511
+253
+1% +$45.2K 0.1% 209
2021
Q1 		$2.26M Buy
17,258
+41
+0.2% +$5.94K 0.06% 269
2020
Q4 		$1.8M Buy
17,217
+6,078
+55% +$615K 0.05% 291
2020
Q3 		$788K Buy
11,139
+3,229
+41% +$225K 0.03% 471
2020
Q2 		$508K Buy
+7,910
New +$433K 0.02% 585

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Stratos Wealth Partners's MRNA Position: Q4 2024 in Review

Stratos Wealth Partners sold out of Moderna (MRNA) in Q4 2024, closing a stake of 3,940 shares — an estimated $263K sold.

Stratos Wealth Partners first reported a position in MRNA in Q2 2020 and held it in 18 quarters. The position peaked at $5.88M in Q3 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Stratos Wealth Partners reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Stratos Wealth Partners sold 3,940 Moderna shares in Q4 2024, an estimated $263K.
  • Stratos Wealth Partners first reported a position in Moderna in Q2 2020 and held it in 18 quarters.
  • Stratos Wealth Partners's Moderna position peaked at $5.88M in Q3 2021.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Stratos Wealth Partners's 13F filing for Q4 2024, filed 27 Jan 2025.